Aristides Capital’s Immatics IMTX Stock Holding History

Aristides Capital’s Portfolio IMTX Stock Details IMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-28,900	Closed	-$205K	–	276
2024 Q4	$205K	Buy	+28,900	New	+$248K	0.04%	234

Other funds holding IMTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Aristides Capital's IMTX Position: Q1 2025 in Review

Aristides Capital sold out of Immatics (IMTX) in Q1 2025, closing a stake of 28,900 shares — an estimated $205K sold.

Aristides Capital first reported a position in IMTX in Q4 2024 and held it in 1 quarter. The position peaked at $205K in Q4 2024. 76 funds tracked by Wall St. Rank hold IMTX as of Q1 2025.

Aristides Capital reported no remaining Immatics position as of Q1 2025 after selling out during the quarter.
Aristides Capital sold 28,900 Immatics shares in Q1 2025, an estimated $205K.
Aristides Capital first reported a position in Immatics in Q4 2024 and held it in 1 quarter.
Aristides Capital's Immatics position peaked at $205K in Q4 2024.
76 funds tracked by Wall St. Rank held Immatics as of Q1 2025.

Based on Aristides Capital's 13F filing for Q1 2025, filed 14 May 2025.